WHEN AN ONLINE PHARMACY IS TOO EASY TO USE


By Judit Mora, CEO and Co-founder, Nuumad


Online pharmacies have made it easier to seek treatment which is valuable for patients, but it also means more clinical decisions begin with a screen. The way that screen is designed can affect what a patient discloses, what a pharmacist notices and whether a request is paused when it should be.


In technology, we talk about “dark UX”, the design that steers someone towards the outcome a business wants. The obvious examples are familiar from subscription sites, where the button to stay is prominent and the link to cancel is hard to find. In pharmacy, the choices can be subtler and the stakes considerably higher.


Consider a patient requesting a prescription medicine online. The platform may ask all the right questions, but does it make a concerning answer stand out when the pharmacist reviews it? If two answers conflict, does the system prompt a follow up conversation? Can the pharmacist pause the request easily, or is the workflow built around getting it completed?


Weight-loss medicines such as GLP-1 treatments show why this matters. An online journey might feel straightforward to a patient, but the prescribing decision depends on information that may need checking and a fuller conversation about suitability. The design should make it easy to identify when that conversation is needed, rather than treating every completed form as a request ready to move forward. The same principle applies to any treatment accessed through an online service.


We often judge digital services by how quickly people can complete a task. In pharmacy, we need to ask, what is the system making easy?


The best pharmacy technology makes the right next step clear, even when that step is to stop and ask another question.


None of this is an argument for making digital care difficult. Patients should be able to describe their needs clearly, and pharmacists should be able to find relevant information without searching through pages of text. Good design can make a service more accessible and give clinicians more time to focus on the person seeking care, but a safe journey sometimes needs to slow down. A patient may need a conversation before a decision can be made. A pharmacist may need to check information that does not quite add up. The right outcome may be a different treatment, a referral or no medicine at all. The system should support those decisions just as readily as it supports a supply.


A platform can work exactly as intended and still make a clinical decision harder. If an important warning gets lost among routine notifications, or conflicting answers are difficult to spot, the pharmacist may miss something they need to investigate. Even the order in which treatments appear can influence what patients consider first. Those choices need the same scrutiny as the clinical checks built into the service.


And with AI being part of most digital systems these days, it adds another layer of complexity. It can help organise patient information and highlight something a clinician might need to investigate. If it also influences which requests progress or which treatment is suggested, pharmacists need to understand how that suggestion was reached and be able to challenge


it. The value of a faster workflow disappears if it makes an uncertain decision look straightforward.


There is already considerable attention on how medicines are promoted online and on safeguards around remote prescribing. We should give the design of the journey between an advertisement and a clinical decision the same attention. A service can avoid an obviously misleading claim while still nudging a patient towards a particular choice or making it too easy to move past a concern.


Pharmacy owners should be able to ask their technology providers practical questions like ‘what does the pharmacist see when a patient’s answers conflict?’ or ‘how does the system handle a request that should pause?’. The answers reveal far more about a platform than a demonstration of how quickly a consultation can be completed.


Those of us who design technology for pharmacies have a responsibility to involve clinical expertise in these choices, including when we use AI tools to build new features. We should test whether the system supports a safe decision when the answer is uncertain, not simply whether it helps the user reach the end of the journey.


Convenience can be a real benefit to patients but it becomes a problem when completing the transaction is easier than exercising clinical judgement. The best pharmacy technology makes the right next step clear, even when that step is to stop and ask another question.


pharmacyinfocus.co.uk 31


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48